Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Summary of Segment Performance (Details)

v3.21.1
Segment Information - Summary of Segment Performance (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Net revenue $ 1,118 $ 1,374
Cost of revenue 1,373 1,584
Gross loss (255) (210)
Vascular [Member]    
Segment Reporting Information [Line Items]    
Net revenue 4 113
Cost of revenue 399 661
Gross loss (395) (548)
Dermatology [Member]    
Segment Reporting Information [Line Items]    
Net revenue 1,114 1,261
Cost of revenue 974 923
Gross loss $ 140 $ 338